Advertisement
Home Blog Page 2809
Retinyl propionate and climbazole is associated with clinical improvement in moderately photodamaged skin for women aged 40 to 70 years

Retinyl Propionate, Climbazole Improves Photodamaged Skin

0
Significant improvement in antiaging benefits versus 0.1 percent retinol, with minimal irritation
For cognitively impaired individuals

Light Therapy Shows Moderate Benefits for Cognitively Impaired

0
Review indicates moderate effect on behavioral disturbances, depression; small effect on sleep
Renal transplant recipients have increased risk of developing melanoma

Intel Gained on Melanoma Risk for Renal Transplant Patients

0
Age-standardized relative rate of melanoma 4.9 in U.S. Renal Data System versus SEER patients
For infants with gastroesophageal reflux disease

Variation in Management for Infants With GERD

0
Variation in overall utilization of anti-reflux surgery, and in surgical and diagnostic approach
After years of increases in binge drinking among college students

Binge Drinking Down Among Young College Students

0
But study also shows those rates are rising for young adults who are not in school
Although more American adolescents are listening to music via earphones than ever before

U.S. Adolescents Exhibit Little Change in Hearing Loss

0
Hearing loss initially jumped between 2007 and 2008, but then dropped back down by 2010
For children and adolescents

Serum γ-Glutamyltransferase Linked to MetS in Children, Teens

0
Increased odds ratios for metabolic syndrome for boys and girls after multivariable adjustment
For patients with atopic dermatitis

House Dust Mites May Be Carriers for IgE Sensitization in Dermatitis

0
IgE reactivity to bacterial antigens more frequent in atopic dermatitis patients sensitized to HDMs
Census reports have demonstrated an increase in the number of physicians and in the actively licensed U.S. physician-to-population ratio from 2010 to 2016

2016 Saw Increase in Number of Physicians Since 2010 Census

0
Increase in actively licensed U.S. physician-to-population ratio from 2010 to 2016
Tocilizumab (Actemra) combined with a 26-week prednisone taper is superior to either 26-week or 52-week prednisone tapering plus placebo with regard to sustained glucocorticoid-free remission in patients with giant-cell arteritis

Tocilizumab Effective for Treatment of Giant-Cell Arteritis

0
Longer follow-up called for to determine the durability of remission and safety